Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of GC1008 in Patients With Primary Myelofibrosis (PMF), Post-polycythemia Vera/Essential Thrombocythemia Related Myelofibrosis (Post-PV/ET MF)

NCT01291784 is registered in ClinicalTrials.gov with John Mascarenhas as lead sponsor.

NCT NCT01291784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01291784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of GC1008 in Patients With Primary Myelofibrosis (PMF), Post-polycythemia Vera/Essential Thrombocythemia Related Myelofibrosis (Post-PV/ET MF)
Lead sponsor
John Mascarenhas
Phase
Phase 1
Overall status
Terminated
Start date
February 28, 2011
Completion date
January 31, 2013
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myelofibrosis, polycythemia vera, post-polycythemic myelofibrosis phase, post-essential thrombocythemia related myelofibrosis, primary myelofibrosis